Opportunity for a pharmacist to review the eLearning content for Chronic Lymphocytic Leukaemia

The Education and Training Subcommittee are in the process of updating the eLearning content on the BOPA website. As part of this update, we are looking for an experienced pharmacist to review the eLearning content for Chronic Lymphocytic Leukaemia (CLL). If you are currently managing policies related to CLL, have a minimum experience of 3 years in oncology, with significant experience in haemato-oncology, we would be delighted to have you apply as a reviewer.

As part of this important role we kindly request you to provide the following details:

Your current role and title:
Place of work: 

Additionally, we ask that you submit a brief statement (no more than 300 words) explaining why you are well suited for this role.

Your insights and expertise are crucial in ensuring the quality and relevance of our content.

To apply, please email [email protected]. Please note, applications will close on Monday 20th January and we will let candidates know the outcome by 31st January.

The selected reviewer will be remunerated for their valuable time and dedication to this initiative. We understand the significance of your contributions and as a token of appreciation, the reviewer will be acknowledged on our website.

Thank you for considering this opportunity, and we appreciate your continued dedication to enhancing healthcare knowledge.

Best wishes,

BOPA eLearning Team

Latest News

By BOPA Committee on 22nd January 2025

NIHR INSIGHT Programme South London Research Masters Studentships 2025/26: Call for applications

NIHR INSIGHT Programme South London Research Masters Studentships 2025/26: Call for applications is now open. For more info click here and/or see flyer below.  

Read article
By BOPA research committee on 22nd January 2025

SURVEY: Examining barriers to pharmacy professionals engaging with research

The Incubator for Pharmacy Professionals is an NIHR-supported initiative dedicated to strengthening research capacity within the pharmacy profession. Despite its critical role as a pillar of professional practice, research remains…

Read article
By BOPA on 20th January 2025

Monographs for use of immunosuppressants in Immune-related adverse events (irAEs)

The Immune-Related Adverse Effects that arise from use of checkpoint inhibitors can be difficult to manage, especially when steroids are not enough. Despite there being guidance about how to manage…

Read article
By BOPA Committee on 20th January 2025

UTIC course has been awarded a FIP Seal

UTIC (Understanding targeted therapies and immunotherapies for cancer) course has been awarded a FIP Seal. This is a joint collaboration between BOPA and ISOPP. The FIP Seal for programmes is…

Read article